Health Care/Hospital
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
* Webcast and conference call to be held today, Tuesday March 10 at 9:30 a.m.
AEDT (Monday March 9 at 6:30 p.m. EDT). Investors can register at the following
link:https://s1.c-conf.com/diamondpass/10053620-ju7y6t.html
2026-03-10 06:34
489
TelkomMetra Streamlines Business Portfolio, AdMedika Group Poised to Enter a New Growth Phase on Regional Level Under Fullerton Health
A Strategic divestment steps to strengthen the fundamentals of TelkomGroup as the main holding and focus on the core business of digital and telecommunications JAKARTA, Indonesia, March 9, 2026 /PRNewswire/ -- PT Multimedia Nusantara (TelkomMetra), as one of the subsidiaries of PT Telkom Indones...
2026-03-09 21:36
3355
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY® in Mainland China
SHANGHAI, March 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the commercial launch of VELSIPITY® (...
2026-03-09 21:27
3339
Court Authorizes Notice of Proposed Class Action Settlement for Farmers, Landscapers and Others Exposed to Weed Killers
ST. LOUIS, March 9, 2026 /PRNewswire/ -- Seeger Weiss LLP, Motley Rice LLC, Waters Kraus Paul & Siegel, Williams Hart & Boundas LLP, The Holland Law Firm, and Ketchmark & McCreight P.C. announce that the Circuit Court of the City of St. Louis, State of Missouri, has granted preliminary approval o...
2026-03-09 20:00
2431
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Atopic Dermatitis
CHENGDU, China, March 9, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug ...
2026-03-09 19:39
1801
IgHM - A New Breakthrough in Immunonutrition
HO CHI MINH CITY, Vietnam, March 9, 2026 /PRNewswire/ -- With an orientated development based on scientific nutrition, VitaDairy (Vietnam) has officially introduced its new ColosBaby Lactoferrin - a nutritional formula, which is utilized with many superior nutrients such as a super-immune complex...
2026-03-09 19:13
1433
CVG Expands Women's Health Portfolio with Strategic Investment in REN Wellness
PETALING JAYA, Malaysia, March 9, 2026 /PRNewswire/ -- Care Ventures Group
(CVG) has announced a strategic investment in REN Health Sdn Bhd, positioning
the company for its next phase as an AI-enabled women's wellness platform.
2026-03-09 19:05
1821
Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
STUART, Fla., March 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the fourth quarter and full year endedDecember 31, 2025, following the close of market onWednesday, March 25, 2026. ...
2026-03-09 19:00
1958
G-NiiB GenieBiome and Ocean Park Conclude Gut Microbiome Education Programme
Two–Year Initiative Reaches Over 200,000 Parents and Children Student Artworks Reflect Early Understanding of Gut Health HONG KONG, March 9, 2026 /PRNewswire/ -- The gut is responsible for more than digestion and is often described as the body's "second brain." Research in recent years has highli...
2026-03-09 17:10
1910
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 9, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today announced ...
2026-03-09 16:32
2528
Leads Biolabs' Opamtistomig (LBL-024) Enrolls First ESCC Patient, Exploring Dual PD-L1/4-1BB Mechanism for Superior Survival Benefits in China's High-Incidence Cancer
NANJING, China, March 9, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK)announced on March 6, 2026 that the first patient has been successfully dosed in a Phase Ⅱ clinical study evaluating Opamtistomig (LBL-024), the company's core inve...
2026-03-09 14:28
1758
Seveno Capital Invests in PointFit as Next-Generation Wearable Patch Signals a Break from Traditional Wearable Devices
Investment in PointFit anchors Seveno's Hong Kong expansion and marks first deal led by new Partner Jean-Baptiste Roy HONG KONG, March 9, 2026 /PRNewswire/ -- Seveno Capital has announced a strategic investment in PointFit, a company developing a skin patch wearable for non-invasive and real-tim...
2026-03-09 10:00
2290
LOTTE Biologics to Participate in DCAT Week 2026 in New York to Explore Global Partnership Opportunities
SEOUL, South Korea, March 9, 2026 /PRNewswire/ -- LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global pharmaceutical and biotechnology industry event taking place in New York from March 23 to 26, to explore new partnership opportunities and strengthen its global p...
2026-03-09 09:54
2101
Global Times: Bluer skies, greener waters, healthier people: Healthy China as the NPC deputies see it
BEIJING, March 8, 2026 /PRNewswire/ -- Building a Healthy China by 2035 is a strategic decision made by the Communist Party ofChina (CPC), and the 15th Five-Year Plan period is critical to achieving this goal, Chinese President Xi Jinping said on Friday, emphasizing the need for coordinated plann...
2026-03-08 18:04
2302
Global Times: Deliver for real, and turn every policy into smiles on people's faces
BEIJING, March 7, 2026 /PRNewswire/ -- "33 million families have received child-rearing subsidies" and "an integrated elderly care service network covering urban and rural areas has taken initial shape"... At the press conference for the fourth session of the 14th National People's Congress (NPC)...
2026-03-07 21:52
2729
Global Times: Understanding 'people' at the heart of Healthy China
"Building a Healthy China by 2035 is a strategic decision made by the Communist Party ofChina (CPC) Central Committee." BEIJING, March 7, 2026 /PRNewswire/ -- On Friday afternoon, Xi Jinping, General Secretary of the CPC Central Committee, visited the members of the Chinese Peasants and Workers ...
2026-03-07 18:47
2717
U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China
SHANGHAI, March 7, 2026 /PRNewswire/ -- Jiahui International Cancer Center
(JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer
(NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy
currently available only in China.
2026-03-07 13:12
2637
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
* Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with high unmet needs. * Transaction represents total equity value of approximately $2.5 billion. SURESNES, France and BRISBANE, Calif., Marc...
2026-03-07 02:30
7337
CARsgen Therapeutics Announces 2025 Annual Results
SHANGHAI, March 6, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2025 Annual Results. Business Highlights * Cash and cash equivalents were around RMB1,123 million as of Decemb...
2026-03-06 20:03
5288
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ -- Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced that ISM4808, an AI-driven PHD inhibitor for chronic kidney disease (CKD)-related anemia previou...
2026-03-06 18:53
2646
Week's Top Stories
Most Reposted
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 309 media titles]
2026-03-04 12:35
Klook's Spring Readiness Index shows how Asia's travelers are preparing for spring travel across Japan, South Korea, and Mainland China
[Picked up by 291 media titles]
2026-03-03 15:49
COL and NASDAQ-Listed BeLive Holdings Unveil World's First "Microdrama in a Box" in Headline Hong Kong FILMART 2026 Launch
[Picked up by 287 media titles]
2026-03-05 17:14
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
[Picked up by 267 media titles]
2026-03-04 10:00
The Ministry of Finance of Thailand, the Bank of Thailand, and the International Monetary Fund Underscore Significant Progress Toward the 2026 IMF-World Bank Group Annual Meetings
[Picked up by 266 media titles]
2026-03-05 12:18
